(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ANTICORPOS ANTI-IL-36R PARA O TRATAMENTO DE PUSTULOSE PALMOPLANTAR

ArquivadaInvention PatentPCT · EP2019086521

Application data

Number

112021010789

Type

Invention Patent

Filing

12/20/2019

Publication

08/31/2021

PCT

EP2019086521

Progress at the INPI

  1. Filing12/20/19
  2. Publication08/31/21
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 12/20/2019 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 06/20/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

DE

See this company's full portfolio

Inventors

C. T. (pessoa física)

DE

J. L. (pessoa física)

DE

P. B. (pessoa física)

DE

S. P. (pessoa física)

DE

Technical data

Priority claims

US

62/785,316 · 12/27/2018

US

62/815,431 · 03/08/2019

US

62/891,464 · 08/26/2019

Abstract

ANTICORPOS ANTI-IL-36R PARA O TRATAMENTO DE PUSTULOSE PALMOPLANTAR. A presente invenção refere-se ao tratamento de ou alívio de sinais e sintomas de pustulose palmoplantar (PPP) com anticorpos anti-IL-36R em um paciente.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

06/20/2023

RPI 2737

Arquivamento - Art. 33 da LPI

#11.1

04/04/2023

RPI 2726

Notificação de entrada na fase nacional - PCT

#1.3

08/31/2021

RPI 2643

Alteração de dados cadastrais

#1.1

06/15/2021

RPI 2632

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.